Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends

Published:2017-07-18 Issue:2 Volume:2 Page:109-123
ISSN:2509-4262
Container-title:PharmacoEconomics - Open
language:en
Short-container-title:PharmacoEconomics Open

Author:

Piatkiewicz Trevor Jozef,Traulsen Janine Marie,Holm-Larsen Tove

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Health Policy,Pharmacology

Link

http://link.springer.com/article/10.1007/s41669-017-0044-1/fulltext.html

Reference75 articles.

1. OECD/EU. Health at a Glance: Europe 2014. Paris: OECD Publishing; 2014.

2. Adamski J, Godman B, Ofierska-Sujkowska G, Osinska B, Herholz H, Wendykowska K, et al. Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers. BMC Health Serv Res. 2010;10:153. doi: 10.1186/1472-6963-10-153 .

3. Duerden M, Gogna N, Godman B, Eden K, Mallinson M, Sullivan N. Current National Initiatives and Policies to Control Drug Costs in Europe: UK Perspective. J Ambul Care Manag. 2004;27(2):132–8.

4. McCabe CJ, Bergmann L, Bosanquet N, Ellis M, Enzmann H, von Euler M, et al. Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective. Ann Oncol. 2009;20(3):403–12. doi: 10.1093/annonc/mdn603 .

5. Cano-Chancel A, Long M, Sparrowhawk K. Risk sharing: what’s at risk and what’s being shared. Value Health. 2010;13(3):A95.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TURKISH EXAMPLE OF PRIORITIZATION AND RESTRICTION DECISIONS IN MEDICINE ACCESS: EVALUATION BASED ON TWO INNOVATIVE DRUGS;Ankara Universitesi Eczacilik Fakultesi Dergisi;2024-08-17

2. It Takes 2 to Tango. Setting Out the Conditions in Which Performance-Based Risk-Sharing Arrangements Work for Both Parties;Value in Health;2024-08

3. Value-based payment for high-cost treatments in Singapore: a qualitative study of stakeholders’ perspectives;International Journal of Technology Assessment in Health Care;2024

4. Reporting reimbursement price decisions for onco-hematology drugs in Spain;Frontiers in Public Health;2023-10-24

5. Implementing outcomes-based risk-sharing agreements: an integrative review of applications in blood cancer in the UK and beyond;Expert Review of Pharmacoeconomics & Outcomes Research;2023-07-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3